Literature DB >> 20534370

Can we stop progression of ankylosing spondylitis?

Georg Schett1, Martin Rudwaleit.   

Abstract

Ankylosing spondylitis is characterised by inflammation of the spine and the entheses followed by bone formation. Excessive bone formation in ankylosing spondylitis leads to the formation of bone spurs, such as syndesmophytes and enthesiophytes, which contribute to ankylosis of joints and poor physical function. This process is based on increased differentiation of osteoblasts from their mesenchymal precursors, which allows to rapidly build up new bone. Prostaglandins, bone morphogenic proteins and Wnt proteins play an essential role in this process. By contrast, tumour necrosis factor (TNF) does not appear to be the direct trigger for osteophyte formation in ankylosing spondylitis. The article reviews the current knowledge regarding the mechanisms and clinical role of ankylosis and explains strategies on how to prevent it in patients with ankylosing spondylitis. Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534370     DOI: 10.1016/j.berh.2010.01.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  28 in total

1.  Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study.

Authors:  Anne C Bay-Jensen; Diana J Leeming; Arndt Kleyer; Sanne S Veidal; Georg Schett; Morten A Karsdal
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

2.  Surgical arthritis service weekly rounds: ankylosing spondylitis.

Authors:  Susan Goodman; Alana Levine; Seth Jerabek; Mark Figgie
Journal:  HSS J       Date:  2011-06-25

3.  Disabling bony ankylosis of hip, knee and axial spine in a neglected patient of ankylosing spondylitis.

Authors:  Ankur Nandan Varshney; Nilesh Kumar; Ravi Anand; Nand Kumar Singh
Journal:  BMJ Case Rep       Date:  2013-07-05

4.  Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.

Authors:  Yong-Gil Kim; Dong Hyun Sohn; Xiaoyan Zhao; Jeremy Sokolove; Tamsin M Lindstrom; Bin Yoo; Chang-Keun Lee; John D Reveille; Joel D Taurog; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

Review 5.  The synovio-entheseal complex in enthesoarthritis.

Authors:  Angelo De Cata; Michele Inglese; Rosa Rubino; Francesca Molinaro; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2015-02-12       Impact factor: 3.984

6.  Bushen Qiangji Granule () medicated serum inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by inhibiting the BMP/Smads signal pathway in vitro.

Authors:  Hong-Xiao Liu; Nan Jiang; Hui-Ying Liang; Ying-Yan Zhou; Xing-Hua Feng; Xiao-Yan Feng; He-Qiu Zhang; Zhi-Kui Wu; Quan Jiang; Jiao Fu; Xiao-Juan Ma; Peng Chen
Journal:  Chin J Integr Med       Date:  2016-10-26       Impact factor: 1.978

7.  Comparison of rates of referral and diagnosis of axial spondyloarthritis before and after an ankylosing spondylitis public awareness campaign.

Authors:  Andrew A Harrison; Christoffel Badenhorst; Sandra Kirby; Douglas White; Josie Athens; Simon Stebbings
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

8.  The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.

Authors:  Fahimeh Jafarnezhad-Ansariha; Mir Saeed Yekaninejad; Ahmad-Reza Jamshidi; Reza Mansouri; Mahdi Vojdanian; Mahdi Mahmoudi; Mohammad Javad Fattahi; Seyed Naser Hashemi; Bernd H A Rehm; Hidenori Matsuo; Emanuela Esposito; Salvatore Cuzzocrea; Abbas Mirshafiey
Journal:  Inflammopharmacology       Date:  2017-08-17       Impact factor: 4.473

Review 9.  Referral strategies for early diagnosis of axial spondyloarthritis.

Authors:  Martin Rudwaleit; Joachim Sieper
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

Review 10.  Bone Involvement in Patients with Spondyloarthropathies.

Authors:  Willem Lems; Corinne Miceli-Richard; Judith Haschka; Andrea Giusti; Gitte Lund Chistensen; Roland Kocijan; Nicolas Rosine; Niklas Rye Jørgensen; Gerolamo Bianchi; Christian Roux
Journal:  Calcif Tissue Int       Date:  2022-01-23       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.